Evidence map›Paper›PMID 39858406›Full record

ArticleBiomolecules2024

A Refined Nomenclature System to Better Discriminate Endo- and Exo-Type Fructanases and Glucanases.

Laura Leaerts, Jaime Ricardo Porras-Domínguez, Maxime Versluys, Wim Van den Ende

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura LeaertsLaboratory of Molecular Plant Biology and KU Leuven Plant Institute, Kasteelpark Arenberg 31, 3001 Leuven, Belgium.ORCID 0009-0008-9025-7710
Jaime Ricardo Porras-DomínguezLaboratory of Molecular Plant Biology and KU Leuven Plant Institute, Kasteelpark Arenberg 31, 3001 Leuven, Belgium.
Maxime VersluysLaboratory of Molecular Plant Biology and KU Leuven Plant Institute, Kasteelpark Arenberg 31, 3001 Leuven, Belgium.ORCID 0000-0003-1331-2233
Wim Van den EndeLaboratory of Molecular Plant Biology and KU Leuven Plant Institute, Kasteelpark Arenberg 31, 3001 Leuven, Belgium.ORCID 0000-0003-1137-3614

Funding

Research Foundation - Flanders G0C4622NResearch Foundation - Flanders G0C6222N
6 · The paper itself

Abstract

Distinguishing between endo- and exo-type enzymes within the glycoside hydrolase (GH) classification presents significant challenges. Traditional methods, often based on endpoint activity measurements, do not capture the full range of products generated, leading to inconsistencies in classification. Not all exo-acting fructanases and glucanases produce monosaccharides (like fructose or glucose), while endo-acting enzymes do not solely produce higher-degree polymerization oligosaccharides. In practice, both enzyme types can yield a variety of products throughout the reaction, complicating classification efforts. To address these challenges, we propose a refined nomenclature system for GH enzymes, including fructanases and glucanases, based on good practices and initial product formation. This system classifies enzymes into four categories for each type: Fr, Fn, Fn,n+1 and F1 for fructanases, and Gr, Gn, Gn,n+1 and G1 for glucanases, based on their mode of action (endo- or exo-based) and initial product profiles. Our refined nomenclature system will advance enzyme structure-function research and support the production and application of fructan and glucan oligosaccharides as prebiotics, priming agents, and potential signaling molecules in microbe-microbe and plant-microbe interactions. Ultimately, this system could benefit agronomy and the food industry, contributing to health improvements.

Indexed as

Glycoside HydrolasesTerminology as TopicOligosaccharidesGlycoside HydrolasesOligosaccharidesendo/exo mechanismfructanasesGH32 familyglucanasesinulinlevannomenclature

Identifiers

PMID39858406
PMCPMC11760859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.